In vitro and in vivo studies of methylseleninic acid: Evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention

Cancer Research

Volumn 60, Issue 11, 2000, Pages 2882-2886

  Ip, Clement ^a   Thompson, Henry J ^b   Zhu, Zongjian ^b   Ganther, Howard E ^c  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLSELENINIC ACID; SELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST HYPERPLASIA; CANCER PREVENTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; FEMALE; MALIGNANT NEOPLASTIC DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; CARCINOGENS; COMET ASSAY; FEMALE; GLUTATHIONE PEROXIDASE; LIVER; LYASES; MAMMARY NEOPLASMS, EXPERIMENTAL; METHYLNITROSOUREA; MICE; NEOPLASMS, EXPERIMENTAL; ORGANOSELENIUM COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; SELENIUM; THIOREDOXIN REDUCTASE (NADPH); TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0034214376     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ganther, H. E., and Lawrence, J. R. Chemical transformations of selenium in living organisms. Improved forms of selenium for cancer prevention. Tetrahedron, 53: 12299-12310, 1997.
2. Vadhanavikit, S., Ip, C., and Ganther, H. E. Metabolites of sodium selenite and methylated selenium compounds administered at cancer chemoprevention levels in the rat. Xenobiotica, 23: 731-745, 1993.
3. Ip, C., and Ganther, H. E. Relationship between the chemical form of selenium and anticarcinogenic activity. In: L. Wattenberg, M. Lipkin, C. W. Boone, and G. J. Kelloff (eds.), Cancer Chemoprevention, pp. 479-488. Boca Raton, FL: CRC Press, 1992.
4. Ip, C. Lessons from basic research in selenium and cancer prevention. J. Nutr., 128: 1845-1854, 1998.
5. Ip, C., and Ganther, H. E. Activity of methylated forms of selenium in cancer prevention. Cancer Res., 50: 1206-1211, 1990.
6. Ip, C., Hayes, C., Budnick, R. M., and Ganther, H. E. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res., 51: 595-600, 1991.
7. Andreadou, I., Menge, W. M. P. B., Commandeur, J. N. M., Worthington, E. A., and Vermeulen, N. P. E. Synthesis of novel Se-substituted selenocysteine derivatives as potential kidney selective prodrugs of biologically active selenol compounds: evaluation of kinetics of β-elimination reactions in rat renal cytosol. J. Med. Chem., 39: 2040-2046, 1996.
8. Ip, C., and Hayes, C. Tissue selenium levels in selenium-supplemented rats and their relevance in mammary cancer protection. Carcinogenesis (Lond.), 10: 921-925, 1989.
9. Ip, C., Zhu, Z., Thompson, H. J., Lisk, D., and Ganther, H. E. Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat. Anticancer Res., 19: 2875-2880, 1999.
10. Ip, C., and Ganther, H. E. Comparison of selenium and sulfur analogs in cancer prevention. Carcinogenesis (Lond.), 13: 1167-1170, 1992.
11. Medina, D., Kittrell, F. S., Liu, Y. J., and Schwartz, M. Morphological and functional properties of TM preneoplastic mammary outgrowths. Cancer Res., 53: 663-667, 1993.
12. Bernhardt, G., Reile, H., Birnbock, H., Sprub, T., and Schonenberger, H. Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J. Cancer Res. Clin. Oncol., 118: 35-43, 1992.
13. Singh, N. P., McCoy, M. T., Tice, R. R., and Schneider, E. L. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res., 175: 184-191, 1988.
14. Collins, A. R., Duthie, S. J., and Dobson, V. L. Direct enzymatic detection of endogenous oxidative base damage in human lymphocyte DNA. Carcinogenesis (Lond.), 14: 1733-1735, 1993.
15. Duke, R. C., and Cohen, J. J. Morphological and biochemical assays of apoptosis. In: J. E. Coligan and A. M. Kruisbeak (eds.), Current Protocols in Immunology, pp. 3.17.1-3.17.16. New York: John Wiley and Sons, 1992.
16. Horvath, P. M., and Ip, C. Synergistic effect of vitamin E and selenium in chemoprevention of mammary carcinogenesis in rats. Cancer Res., 43: 5335-5341, 1983.
17. Olson, O. E., Palmer, I. S., and Carey, E. E. Modification of the official fluorometric method for selenium in plants. J. Assoc. Off. Anal. Chem., 58: 117-121, 1975.
18. Stadtman, T. C. Selenocysteine. Annu. Rev. Biochem., 65: 83-100, 1996.
19. Burk, R. F., and Hill, K. E. Regulation of selenoproteins. Annu. Rev. Nutr., 13: 65-81, 1993.
20. Ip, C., and Lisk, D. J. Bioavailability of selenium from selenium-enriched garlic. Nutr. Cancer, 20: 129-137, 1993.
21. Paglia, D. E., and Valentine, W. N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med., 70: 158-169, 1967.
22. Hill, K. E., McCollum, G. W., Boeglin, M. E., and Burk, R. F. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem. Biophys. Res. Commun., 234: 293-295, 1997.
23. Snedecor, G. J. W., and Cochran, W. G. Statistical Methods, Ed. 6, pp. 135-317. Ames, Iowa: Iowa State University, 1967.
24. Lu, J., Pei, H., Ip, C., Lisk, D. J., Ganther, H., and Thompson, H. J. Effect of an aqueous extract of selenium-enriched garlic on in vitro markers and in vivo efficacy in cancer prevention. Carcinogenesis (Lond.), 17: 1903-1907, 1996.
25. Zhu, Z., Jiang, W., Ganther, H. E., Ip, C., and Thompson, H. J. In vitro effects of Se-allylselenocysteine and Se-propylselenocysteine on cell growth, DNA integrity and apoptosis. Biochem. Pharmacol., in press, 2000.
26. Kice, J. L., and Lee, T. W. S. Oxidation-reduction reactions of organoselenium compounds. I. Mechanism of the reaction between seleninic acids and thiols. J. Am. Chem. Soc., 100: 5094-5102, 1978.
27. Bird, M. L., and Challenger, F. Potassium alkaneselenonates and other alkyl derivatives of selenium. J. Chem. Soc., 1942: 570-574, 1942.
28. Lu, J., Jiang, C., Kaeck, M., Ganther, H., Vadhanavikit, S., Ip, C., and Thompson, H. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem. Pharmacol., 50: 213-219, 1995.
29. Kaeck, M., Lu, J., Strange, R., Ip, C., Ganther, H. E., and Thompson, H. J. Differential induction of growth arrest inducible genes by selenium compounds. Biochem. Pharmacol., 53: 921-926, 1997.
30. Ganther, H. E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis (Lond.), 20: 1657-1666, 1999.